Tehran University of Medical Sciences

Science Communicator Platform

Share By
Immunohistochemistry of Cancers Publisher



Ghanadan A1, 2 ; Jahanzad I3 ; Abbasi A4
Authors

Source: Cancer Immunology: A Translational Medicine Context# Second Edition Published:2020


Abstract

This chapter provides an overview of mostly malignant tumors of various organs with focus on the most common types. The authors have used their own experience in addition to literature review and have discussed the most common and useful immunohistochemistry markers in diagnosis and differential diagnosis of various malignant tumors. Novel prognostic markers are also included. © Springer Nature Switzerland AG 2020.
Related Docs
View other Related Docs
1. Serum Tumor Markers in Chronic Kidney Disease: As Clinical Tool in Diagnosis, Treatment and Prognosis of Cancers, Renal Failure (2016)
2. Immunohistochemistry of Cancers, Cancer Immunology: A Translational Medicine Context (2015)
3. Hurdles in Cancer Immunotherapy, Cancer Immunology: Bench to Bedside Immunotherapy of Cancers# Second Edition (2020)
Experts (# of related papers)
View all Related Experts
Nima Rezaei (8)
Elham Nazar (1)
Other Related Docs
4. Genetic and Epigenetic Alterations in Parathyroid Neoplasms, Iranian Journal of Pathology (2022)
5. Cancer Immunology, Vaccines for Cancer Immunotherapy: An Evidence-Based Review on Current Status and Future Perspectives (2018)
6. Targeting Regulatory T Cells by Curcumin: A Potential for Cancer Immunotherapy, Pharmacological Research (2019)
7. Understanding the Tumor Microenvironment for Effective Immunotherapy, Medicinal Research Reviews (2021)
8. Cancer Immunology, Vaccines for Cancer Immunotherapy: An Evidence-Based Review on Current Status and Future Perspectives (2019)
9. The Paradox of Th17 Cell Functions in Tumor Immunity, Cellular Immunology (2017)
10. Natural Killer Cells and Acute Myeloid Leukemia: Promises and Challenges, Cancer Immunology# Immunotherapy (2022)
11. An Agent-Based Model of Avascular Tumor Growth: Immune Response Tendency to Prevent Cancer Development, Simulation (2017)
12. Myeloid-Derived Suppressor Cells in Gastrointestinal Cancers: A Systematic Review, Journal of Gastroenterology and Hepatology (Australia) (2016)
13. Cancer Immunoprevention: Current Status and Future Directions, Archivum Immunologiae et Therapiae Experimentalis (2021)
14. Cancer Nanomedicine: Special Focus on Cancer Immunotherapy, Cancer Immunology: Bench to Bedside Immunotherapy of Cancers# Second Edition (2020)
15. Tumor-Infiltrating Lymphocyte Therapy for Lung Cancer and Its Future Paradigms, Expert Opinion on Biological Therapy (2022)
16. P16ink4a Immunohistochemistry As a Gold Standard for Cervical Cancer and Precursor Lesions Screening, Iranian Journal of Public Health (2020)
17. Interdigitating Dendritic Cell Tumor of Submandibular Lymph Node: Case Report and Literature Review, Iranian Journal of Pathology (2021)
18. Tumor Antigens, Vaccines for Cancer Immunotherapy: An Evidence-Based Review on Current Status and Future Perspectives (2018)
19. Cell-Based Vaccines: Frontiers in Medical Technology for Cancer Treatment, Regenerative Engineering and Translational Medicine (2024)
20. Dysregulation of Helper T Lymphocytes in Esophageal Squamous Cell Carcinoma (Escc) Patients Is Highly Associated With Aberrant Production of Mir-21, Immunologic Research (2019)